Wei Luo

Buffalo State University

Papers

1

Total Citations

32

H-Index

1

About

Wei Luo is a researcher whose work centers on the intersection of epigenetics, vascular biology, and cancer biology, with a particular focus on the tumor microenvironment. Their most recognized contribution examines how epigenetic alterations — specifically DNA methylation — shape the behavior of endothelial cells within tumor-associated vasculature. In a notable 2011 study that has garnered 32 citations, Luo and colleagues demonstrated that the vitamin D metabolizing gene *CYP24A1* exhibits differential promoter methylation in endothelial cells isolated from malignant versus benign prostate tissue, revealing that tumor-associated blood vessels carry a distinct epigenetic signature compared to those in normal tissue. This work provided compelling evidence that the tumor microenvironment actively reprograms the epigenome of vascular endothelial cells, with important implications for understanding how tumors co-opt their own blood supply. By bridging epigenetic regulation and tumor angiogenesis, Luo's research opens avenues for developing epigenetically targeted therapies aimed not only at cancer cells but at the supporting vasculature that sustains tumor growth.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Differential vitamin D 24-hydroxylase/<i>CYP24A1</i>gene promoter methylation in endothelium from benign and malignant human prostate
32 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Buffalo State University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago